Pharming Group Financial Ratios for Analysis 2012-2024 | PHGUF

Fifteen years of historical annual and quarterly financial ratios and margins for Pharming Group (PHGUF).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
202320222021202020192018201720162015201420132012
4.064.655.333.431.051.401.511.213.793.301.900.94
0.430.440.450.460.040.380.760.600.350.030.19-0.34
0.780.810.840.880.501.184.322.450.670.050.39-0.37
89.7291.4689.3788.9187.3783.5986.1170.5055.6783.8283.7559.79
-2.208.876.8235.9436.0428.2524.45-72.70-118.5313.58-100.99-152.68
-2.208.876.8235.9436.0428.2524.45-72.70-118.5313.58-100.99-152.68
4.3015.2816.6839.8639.1033.1028.26-67.94-118.5313.58-100.99-152.68
-4.907.2911.6020.7827.620.63-99.75-110.48-91.96-27.22-220.05-227.01
-4.306.658.0417.7921.4118.50-89.22-110.48-91.96-27.22-220.05-227.01
0.530.480.500.510.740.630.540.130.190.380.220.63
0.440.410.771.111.481.280.680.260.300.260.232.03
5.317.446.635.916.577.597.961.283.3613.637.9620.25
68.6849.0355.0361.7655.5848.1245.8628410926.7745.8718.02
-4.826.688.2920.5834.5840.47-425.26-63.84-41.77-19.32-300.60315
-7.1510.5614.6642.2410726821160.03-43.08-19.84-327.04294
-2.283.214.039.0215.8611.65-48.11-13.83-17.26-10.35-47.95-143.04
-2.743.744.5711.0633.1925.20-102.67-25.61-27.36-18.72-242.24423
0.330.310.300.29-0.120.040.070.060.100.02-0.01
-0.020.030.050.120.110.070.09-0.03-0.04-0.01-0.05-0.18
0.000.030.040.120.110.070.08-0.03-0.05-0.01-0.05-0.18

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-03-312023-12-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-12-31
1.43-4.515.563.554.031.631.601.073.013.362.010.95-
0.12-0.450.440.440.520.340.610.540.350.030.14-0.43-
0.81-0.850.810.831.101.032.492.270.730.040.23-2.04-
84.91-90.4289.5488.8889.0784.6182.9789.0270.3343.7114.24100.00-
-29.35--32.126.0614.4239.4534.7627.3225.05-148.87-171.12-215.43-492.56-
-29.35--32.126.0614.4239.4534.7627.3225.05-148.87-171.12-215.43-492.56-
--------------
-29.91--39.209.0829.3625.0927.5913.98-37.18-152.89-74.61-1,129.95-1,122.31-
-22.39--28.707.4219.5616.9819.1311.28-37.18-152.89-74.61-1,129.95-1,122.31-
0.13-0.100.120.110.160.180.170.120.040.030.040.02-
0.15-0.080.160.220.370.400.230.090.040.070.16--
1.44-1.291.481.321.621.552.050.780.570.752.420.72-
62.65-69.6760.7168.0555.7158.2143.8711615812037.23125-
-6.04--6.121.784.577.259.7610.53-19.86-16.09-4.54-225.4890.02-
-9.04--9.873.078.8422.0739.63-13.4921.13-16.66-4.66-237.9383.10-
-2.82--2.890.882.082.763.381.95-4.37-6.07-2.47-48.29-18.48-
-5.31--3.351.002.543.486.404.06-9.11-10.53-4.40-194.38129-
----0.290.200.13-0.070.060.080.03-0.06-
-0.010.00-0.040.000.010.030.020.00-0.01-0.01-0.01-0.02-0.030.00
-0.01--0.040.000.010.030.020.00-0.01-0.01-0.01-0.02-0.03-